Tcg Crossover Management, LLC Savara Inc Transaction History
Tcg Crossover Management, LLC
- $490 Million
- Q2 2025
A detailed history of Tcg Crossover Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 12,362,205 shares of SVRA stock, worth $31.9 Million. This represents 5.75% of its overall portfolio holdings.
Number of Shares
12,362,205
Previous 12,362,205
-0.0%
Holding current value
$31.9 Million
Previous $34.2 Million
17.69%
% of portfolio
5.75%
Previous 8.25%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
128Shares Held
167MCall Options Held
38.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD24.5MShares$63.1 Million4.63% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$45.4 Million12.04% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$29.6 Million1.38% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$28.4 Million1.32% of portfolio
-
Vr Adviser, LLC New York, NY8.88MShares$22.9 Million4.01% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $294M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.